menu toggle

FormularyDecisions for payers

Access evidence for thousands of products—all from one site

Join the largest online community of your peers in reviewing products in both the pre-launch and post-launch stages for formulary placement decisions
professionals around computer monitor

Streamline the formulary decision making process

FormularyDecisions is a secure online platform that facilitates the exchange of information between payers and life sciences companies to provide healthcare decision makers with the evidence, resources, and tools to support the product evaluation process. With FormularyDecisions, you can quickly access the information you need on thousands of products all from one site.
professionals around computer monitor

Acquire product information early

Enhance the way you gather product data via a single, secure 24/7 platform. There are over 3,000 FDA-approved and pipeline products on the platform. Gain compliant access to the information you deem most critical when considering formulary decisions. In addition, there are over 1 million evidence links to leading scientific resources including FDA, CDC, NIH, JAMA, PubMed, and more – offering you a more efficient method to source information in support of your product needs.
pharmacist looking at bottle

Understand the US biosimilars market and laws governing every state

Gain centralized access to all pertinent biosimilar information in the US through the biosimilars hub. The hub provides FDA guidance on biosimilars, manufacturer resources, and serves as an exclusive repository for substitution laws for all 50 states.
professionals around computer monitor

Connect with manufacturers

More than 500 manufacturers (pharma, biotech, medical device) are featured on the platform providing information that includes disease and therapeutic information, abstracts, posters, monographs, and pivotal clinical studies. eDossiers allow users to automatically access manufacturer product information once it becomes available to support the product review process.

Determine the cost effectiveness of products

FormularyDecisions is also the home to reports generated by the Institute for Clinical and Economic Review (ICER). ICER Reports assist decision makers in determining the cost effectiveness of products in specific disease states as compared to similar products.

FormularyDecisions for payers platform brochure

Ready to get started?

Insights for payers from FormularyDecisions

Six insights driving the evolution of FormularyDecisions®

Are US payers getting to grips with cost-effectiveness analysis?

Webinar: the evolution of value assessment in the US: considerations and controversies

People around a table having a discussion

FormularyDecisions for healthcare decision makers feature highlight:

Product Snapshots

Preview a Product Snapshot to see the type of information provided on FormularyDecisions. These expert pipeline product overviews are available at no cost for eligible healthcare decision makers.
Xcenda_Split_Image_Header

FormularyDecisions for healthcare decision makers feature highlight:

Clinical Guidelines Snapshot

Our new Clinical Guideline Snapshots feature makes finding expert summaries of published clinical guidelines easy. We’ve partnered with the clinical experts at The Medical Letter to provide you with all the latest product and disease state updates you need to know — summarized for you in one convenient place.